Aker BioMarine reports 17% revenue growth in 2020 amid krill EPA/DHA launch and COVID-19 hurdles

The company also entered a research collaboration for its Lysoveta krill ingredient’s potential for Alzheimer’s

Related Articles

FormattedPicture

BUSINESS NEWS

18 Jun 2021 --- This week in industry news, Kate Farms, a producer of plant-based nutritional formulas, set out for expansion after securing a US$30 million senior credit facility... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

11 Jun 2021 --- This week in industry news, Aker BioMarine’s krill protein hydrolysate product Invi was determined to be Generally Recognized as Safe (GRAS) and Sabi-Sabinsa... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

28 May 2021 --- In nutrition news this week, the Ingredient Transparency Center’s Collagen Stewardship Alliance (CSA) added three major companies to its supporters list. The... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

25 May 2021 --- Beta-sitosterol, a natural food sterol traditionally known to reduce cholesterol levels, has acutely reduced anxiety in a mouse study from the Weizmann Institute of... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

18 May 2021 --- The debate over omega 3’s health benefits has been reignited by new research from the Intermountain Healthcare Heart Institute (IHHI) in Salt Lake City,... Read More

trans